4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-25-000013
Chief Operating Officer sold 7,636 shares at $1.86 ($14,225)
- Chief Operating Officer acquired 49,800 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barton Russell Chief Operating Officer | 2025-01-03 | Sale 10b5-1 | −7,636 | $1.86 | $14,225 | 89,231 | D |
| Barton Russell Chief Operating Officer | 2025-01-06 | Grant or award 10b5-1 | +49,800 | 139,031 | D | ||
| Derivatives | |||||||
| Barton Russell Chief Operating Officer | 2025-01-06 | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +74,700 | 74,700 | D | ||
| Open-market sales · 7,636 sh · avg $1.86 · $14,225 | |||||||
Loading xslF345X05/wk-form4_1736297739.xml…